Development of a Human Immunodeficiency Virus Risk Prediction Model Using Electronic Health Record Data From an Academic Health System in the Southern United States
Charles M. Burns(Duke Medical Center), Meredith E. Clement(Louisiana State University Health Sciences Center New Orleans)
Cited by 30
Related Papers
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847
Long-acting injectable cabotegravir for the prevention of HIV infection
|Current Opinion in HIV and AIDS|2019|106